Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Theranostics: A Historical Perspective of Cancer Nanotechnology Paving the Way for Simultaneous Use Applications

  • Chapter
  • First Online:
Nanotheranostics for Cancer Applications

Part of the book series: Bioanalysis ((BIOANALYSIS,volume 5))

Abstract

Our modern view of theranostics derived from the initial intent to improve cancer patient outcomes by linking the selection and delivery of therapeutics to the results of diagnostic testing. This effort to combine diagnosis with therapy began in the 1990s along with the potential of using nanotechnology to do so. This was driven in part by dedicated cooperative funding efforts, such as the National Nanotechnology Initiative (2000) and the National Cancer Institute’s Alliance for Nanotechnology in Cancer (2004), but additionally by novel tools and fundamental science. Yet, our modern day understanding of cancer as well as materials at the nanoscale began long before the visualization of any of these lofty goals. The progress in the application of nanotechnology to cancer diagnosis and treatment is charted in this chapter to offer historical context of our past and to help drive our future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shi, J., Kantoff, P.W., Wooster, R., Farokhzad, O.C.: Cancer nanomedicine: progress, challenges and opportunities. Nat. Rev. Cancer. 17, 20–37 (2017). https://doi.org/10.1038/nrc.2016.108

    Article  Google Scholar 

  2. Chan, W.C.W.: Nanomedicine 2.0. Acc. Chem. Res. 50, 627–632 (2017). https://doi.org/10.1021/acs.accounts.6b00629

    Article  Google Scholar 

  3. Natfji, A.A., Ravishankar, D., Osborn, H.M.I., Greco, F.: Parameters affecting the enhanced permeability and retention effect: the need for patient selection. J. Pharm. Sci. 106, 3179–3187 (2017). https://doi.org/10.1016/j.xphs.2017.06.019

    Article  Google Scholar 

  4. Hartshorn, C.M., Bradbury, M.S., Lanza, G.M., et al.: Nanotechnology strategies to advance outcomes in clinical cancer care. ACS Nano. 12, 24 (2017). https://doi.org/10.1021/acsnano.7b05108

    Article  Google Scholar 

  5. Coleman, M.P.: War on cancer and the influence of the medical-industrial complex. J. Cancer Policy. 1, e31–e34 (2013). https://doi.org/10.1016/j.jcpo.2013.06.004

    Article  Google Scholar 

  6. Macilwain, C.: Change the cancer conversation. Nat News. 520, 7 (2015). https://doi.org/10.1038/520007a

    Article  Google Scholar 

  7. World Health Organization WHO Cancer Fact Sheet 2017. In: WHO. http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed 1 Aug 2017

  8. National Cancer Institute Cancer Statistics. In: Natl. Cancer Inst. https://www.cancer.gov/about-cancer/understanding/statistics. Accessed 2 Aug 2017

  9. Siegel, R.L., Miller, K.D., Jemal, A.: Cancer statistics, 2015. CA Cancer J. Clin. 65, 5–29 (2015). https://doi.org/10.3322/caac.21254

    Article  Google Scholar 

  10. American Cancer Society The History of Cancer. https://www.cancer.org/cancer/cancer-basics/history-of-cancer.html. Accessed 1 Dec 2017

  11. National Cancer Institute Progress in Cancer Research. In: Natl. Cancer Inst. https://www.cancer.gov/research/progress. Accessed 1 Dec 2017

  12. Hanahan, D., Weinberg, R.A.: The hallmarks of cancer. Cell. 100, 57–70 (2000). https://doi.org/10.1016/S0092-8674(00)81683-9

    Article  Google Scholar 

  13. Hanahan, D., Weinberg, R.A.: Hallmarks of cancer: the next generation. Cell. 144, 646–674 (2011). https://doi.org/10.1016/j.cell.2011.02.013

    Article  Google Scholar 

  14. Faraday, M.: The Bakerian lecture: experimental relations of gold (and other metals) to light. Philos. Trans. R. Soc. Lond. 147, 145–181 (1857)

    Google Scholar 

  15. Feynman, R.: There’s plenty of room at the bottom. In: American Physical Society Annual Meeting. Pasadena, CA (1959)

    Google Scholar 

  16. Taniguchi, N.: On the basic concept of nanotechnology. In: Proceedings of the International Conference on Production Engineering (1974)

    Google Scholar 

  17. Binnig, G., Rohrer, H.: Scanning tunneling microscopy. IBM J. Res. Dev. 30, 355–369 (1986)

    Google Scholar 

  18. Binnig, G., Quate, C.F., Gerber, C.: Atomic force microscope. Phys. Rev. Lett. 56, 930–933 (1986). https://doi.org/10.1103/PhysRevLett.56.930

    Article  Google Scholar 

  19. Kroto, H.W., Heath, J.R., O’Brien, S.C., et al.: C60: Buckminsterfullerene. Nature. 318, 162 (1985). https://doi.org/10.1038/318162a0

    Article  Google Scholar 

  20. Ekimov, A.I., Efros, A.L., Onushchenko, A.A.: Quantum size effect in semiconductor microcrystals. Solid State Commun. 56, 921–924 (1985). https://doi.org/10.1016/S0038-1098(85)80025-9

    Article  Google Scholar 

  21. Gabizon, A., Bradbury, M., Prabhakar, U., et al.: Cancer nanomedicines: closing the translational gap. Lancet. 384, 2175–2176 (2014). https://doi.org/10.1016/S0140-6736(14)61457-4

    Article  Google Scholar 

  22. Anselmo, A.C., Mitragotri, S.: Nanoparticles in the clinic. Bioeng. Transl. Med. 1, 10–29 (2016). https://doi.org/10.1002/btm2.10003

    Article  Google Scholar 

  23. Bainbridge, W., Roco, M.: Handbook of Science and Technology Convergence. Springer International Publishing, Switzerland (2016)

    Book  Google Scholar 

  24. Wang, P.C., Blumenthal, R.P., Zhao, Y., et al.: Building scientific progress without borders: nanobiology and nanomedicine in China and the U.S. Cancer Res. 69, 5294–5295 (2009). https://doi.org/10.1158/0008-5472.CAN-09-0563

    Article  Google Scholar 

  25. Nagahara, L.A., Lee, J.S.H., Molnar, L.K., et al.: Strategic workshops on cancer nanotechnology. Cancer Res. 70, 4265–4268 (2010). https://doi.org/10.1158/0008-5472.CAN-09-3716

    Article  Google Scholar 

  26. Ptak, K., Farrell, D., Panaro, N.J., et al.: The NCI alliance for nanotechnology in cancer: achievement and path forward. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2, 450–460 (2010). https://doi.org/10.1002/wnan.98

    Article  Google Scholar 

  27. Goldberg, M.S., Hook, S.S., Wang, A.Z., et al.: Biotargeted nanomedicines for cancer: six tenets before you begin. Nanomed. 8, 299–308 (2013). https://doi.org/10.2217/nnm.13.3

    Article  Google Scholar 

  28. Bainbridge, W.S., Roco, M.C.: Science and technology convergence: with emphasis for nanotechnology-inspired convergence. J. Nanopart. Res. 18, 211 (2016). https://doi.org/10.1007/s11051-016-3520-0

    Article  Google Scholar 

  29. Chakravarthy, R., Cotter, K., DiMasi, J.A., et al.: Public and Private Sector Contributions to the Research and Development of the Most Transformational Drugs of the Last 25 Years. Tufts University (2015)

    Google Scholar 

  30. Avorn, J.: The $2.6 billion pill — methodologic and policy considerations. N. Engl. J. Med. 372, 1877–1879 (2015). https://doi.org/10.1056/NEJMp1500848

    Article  Google Scholar 

  31. DiMasi, J.A., Grabowski, H.G., Hansen, R.W.: Innovation in the pharmaceutical industry: new estimates of R&D costs. J. Health Econ. 47, 20–33 (2016). https://doi.org/10.1016/j.jhealeco.2016.01.012

    Article  Google Scholar 

  32. Shi, J., Xiao, Z., Kamaly, N., Farokhzad, O.C.: Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc. Chem. Res. 44, 1123–1134 (2011). https://doi.org/10.1021/ar200054n

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Cancer Institute, NIH, Nanodelivery Systems and Devices Branch, Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, Rockville, MD, USA

    Christopher M. Hartshorn & Stephanie A. Morris

Authors
  1. Christopher M. Hartshorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephanie A. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephanie A. Morris .

Editor information

Editors and Affiliations

  1. Department of Chemical Engineering, University of Massachusetts Lowell, Lowell, MA, USA

    Prakash Rai

  2. National Cancer Institute, NIH Nanodelivery Systems and Devices Branch Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, Rockville, MD, USA

    Stephanie A. Morris

Rights and permissions

Reprints and permissions

Copyright information

© 2019 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hartshorn, C.M., Morris, S.A. (2019). Theranostics: A Historical Perspective of Cancer Nanotechnology Paving the Way for Simultaneous Use Applications. In: Rai, P., Morris, S.A. (eds) Nanotheranostics for Cancer Applications. Bioanalysis, vol 5. Springer, Cham. https://doi.org/10.1007/978-3-030-01775-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-01775-0_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-01773-6

  • Online ISBN: 978-3-030-01775-0

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics

Search

Navigation